79344 Federal Register / Vol. 75, No. 243 / Monday, December 20, 2010 / Notices 

numbers for the CFTC’s regulations 

were published on December 30, 1981. 

See 46 FR 63035 (Dec. 30, 1981). The 

Federal Register notice with a 60-day 

comment period soliciting comments on 

this collection of information was 

published on August 14, 2007 (72 FR 

45420). 

Burden statement: The respondent 

burden for this collection is estimated to 

average .10 hours per response to file 

the brief written statement. This 

estimate includes the time needed to 

review instructions; develop, acquire, 

install, and utilize technology and 

systems for the purposes of collecting, 

validating, and verifying information, 

processing and maintaining information 

and disclosing and providing 

information; adjust the existing ways to 

comply with any previously applicable 

instructions and requirements; train 

personnel to be able to respond to a 

collection of information; and transmit 

or otherwise disclose the information. 

Respondents/Affected Entities: 3. 

Estimated number of responses: 4.5. 

Estimated total annual burden on 

respondents: .10 hours. 

Frequency of collection: On occasion. 

Send comments regarding the burden 

estimated or any other aspect of the 

information collection, including 

suggestions for reducing the burden, to 

the addresses listed below. Please refer 

to OMB Control No. 3038–0025 in any 

correspondence. 

John P. Dolan, Office of General 

Counsel, U.S. Commodity Futures 

Trading Commission, 1155 21st Street, 

NW., Washington, DC 20581 and Office 

of Information and Regulatory Affairs, 

Office of Management and Budget, 

Attention: Desk Officer for CFTC, 725 

17th Street, Washington, DC 20503. 

Dated: December 15, 2010. 

David A. Stawick, 

Secretary of the Commission. 

[FR Doc. 2010–31900 Filed 12–17–10; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Meeting of the Uniform Formulary 

Beneficiary Advisory Panel 

AGENCY: Assistant Secretary of Defense 

(Health Affairs), DoD. 

ACTION: Notice of meeting. 

SUMMARY: Under the provisions of the 

Federal Advisory Committee Act of 

1972 (Title 5, United States Code 

(U.S.C.), Appendix, as amended) and 

the Government in the Sunshine Act of 

1976 (5 U.S.C. 552b, as amended) the 

Department of Defense announces the 

following Federal Advisory Committee 

Meeting of the Uniform Formulary 

Beneficiary Advisory Panel (hereafter 

referred to as the Panel). 

DATES: January 6, 2011, from 9 a.m.–12 

p.m. 

ADDRESSES: Naval Heritage Center 

Theater, 701 Pennsylvania Avenue, 

NW., Washington, DC 20004. 

FOR FURTHER INFORMATION CONTACT: 

Lieutenant Colonel Stacia Spridgen, 

Designated Federal Officer, Uniform 

Formulary Beneficiary Advisory Panel 

2450 Stanley Road, Suite 208, Ft. Sam 

Houston, TX 78234–6102, Telephone: 

(210) 295–127, Fax: (210) 295–2789, Email Address: 

Baprequests@tma.osd.mil. 

SUPPLEMENTARY INFORMATION: 

Purpose of Meeting: The Panel will 

review and comment on 

recommendations made to the Director, 

TRICARE Management Activity, by the 

Pharmacy and Therapeutics Committee 

regarding the Uniform Formulary. 

Meeting Agenda: 

1. Sign-In. 

2. Welcome and Opening Remarks. 

3. Public Citizen Comments. 

4. Scheduled Therapeutic Class 

Reviews (Comments will follow each 

agenda item). 

a. Non-Insulin Anti-Diabetic Drugs. 

b. Designated Newly Approved Drugs 

in Already-Reviewed Classes. 

c. Pertinent Utilization Management 

Issues. 

d. Drugs Recommended for NonFormulary Placement Due to NonCompliance with the National Defense 

Authorization Act for Fiscal Year 2008, 

Section 703. 

5. Panel Discussions and Vote. 

Meeting Accessibility: Pursuant to 5 

U.S.C. 552b, as amended, and Title 41, 

Code of Federal Regulations (CFR), 102– 

3.140 through 102–3.165, and the 

availability of space, this meeting is 

open to the public. Seating is limited 

and will be provided only to the first 

220 people signing-in. All persons must 

sign-in legibly. 

Administrative Work Meeting: Prior to 

the public meeting, the Panel will 

conduct an Administrative Work 

Meeting from 8 a.m. to 9 a.m. to discuss 

administrative matters of the Panel. The 

Administrative Work Meeting will be 

held at the Naval Heritage Center, 701 

Pennsylvania Avenue, NW., 

Washington, DC, 20004. Pursuant to 41 

CFR 102–3.160, the Administrative 

Work Meeting will be closed to the 

public. 

Written Statements: Pursuant to 41 

CFR 102–3.105(j) and 102–3.140, the 

public or interested organizations may 

submit written statements to the 

membership of the Panel at any time or 

in response to the stated agenda of a 

planned meeting. Written statements 

should be submitted to the Panel’s 

Designated Federal Officer (DFO). The 

DFO’s contact information can be 

obtained from the General Services 

Administration’s Federal Advisory 

Committee Act Database—https:// 

www.fido.gov/facadatabase/public.asp. 

Written statements that do not pertain 

to the scheduled meeting of the Panel 

may be submitted at any time. However, 

if individual comments pertain to a 

specific topic being discussed at a 

planned meeting, then these statements 

must be submitted no later than five 

business days prior to the meeting in 

question. The DFO will review all 

submitted written statements and 

provide copies to all the committee 

members. 

Public Comments: In addition to 

written statements, the Panel will set 

aside one hour for individuals or 

interested groups to address the Panel. 

To ensure consideration of their 

comments, individuals and interested 

groups should submit written 

statements as outlined in this notice; but 

if they still want to address the Panel, 

then they will be afforded the 

opportunity to register to address the 

Panel. The Panel’s DFO will have a 

‘‘Sign-Up Roster’’ available at the Panel 

meeting, for registration on a first-come, 

first-serve basis. Those wishing to 

address the Panel will be given no more 

than five minutes to present their 

comments, and at the end of the onehour time period, no further public 

comments will be accepted. Anyone 

who signs up to address the Panel, but 

is unable to do so due to the time 

limitation, may submit comments in 

writing; however, he or she must 

understand that written comments may 

not be reviewed prior to the Panel’s 

deliberation. Accordingly, the Panel 

recommends that individuals and 

interested groups consider submitting 

written statements instead of addressing 

the Panel. 

Dated: December 14, 2010. 

Morgan F. Park, 

Alternate OSD Federal Register Liaison 

Officer, Department of Defense. 

[FR Doc. 2010–31791 Filed 12–17–10; 8:45 am] 

BILLING CODE 5001–06–P 


jlentini on DSKJ8SOYB1PROD with NOTICES